Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Karyopharm Therapeutics (KPTI) Tax Rate (2017 - 2025)

Karyopharm Therapeutics' Tax Rate history spans 9 years, with the latest figure at 0.07% for Q4 2025.

  • For Q4 2025, Tax Rate fell 43.0% year-over-year to 0.07%; the TTM value through Dec 2025 reached 1.19%, down 112.0%, while the annual FY2025 figure was 1.19%, 112.0% down from the prior year.
  • Tax Rate reached 0.07% in Q4 2025 per KPTI's latest filing, up from 0.1% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 0.35% in Q4 2024 to a low of 0.39% in Q2 2023.
  • Average Tax Rate over 5 years is 0.12%, with a median of 0.14% recorded in 2021.
  • Peak YoY movement for Tax Rate: skyrocketed 86bps in 2021, then crashed -43bps in 2025.
  • A 5-year view of Tax Rate shows it stood at 0.13% in 2021, then crashed by -109bps to 0.27% in 2022, then skyrocketed by 147bps to 0.13% in 2023, then soared by 174bps to 0.35% in 2024, then plummeted by -121bps to 0.07% in 2025.
  • Per Business Quant, the three most recent readings for KPTI's Tax Rate are 0.07% (Q4 2025), 0.1% (Q3 2025), and 0.11% (Q2 2025).